Presentation on Nordic Life Science Congress and updated Investor Presentation – Lifecare Newsletter

Bergen, Norway 7 October 2022 

Watch Lifecare's company presentation at the LSX Nordic Congress for Lice
Science and Investor executives in Copenhagen, take a look at our updated
investor presentation and our new animation video explaining our technology.   
Read more in Lifecare's newsletter:
https://lifecare.no/news/information-from-lifecare-october-2022/


This is Lifecare 
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE). 

Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no,
+47 40 05 90 40 

This stock exchange announcement was published by Joacim Holter, CEO at Lifecare
AS, on 7.10.22 at 15:09 CET.